Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PBR vs GSK✓SelectedUSD · GSKPBR vs GSK performance historyLatest closeAs of+1.33%11/13
Stock and ETF performance explorer

PBR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.9%
GSK return
+9.8%
Excess return
+37.1%
Maximum drawdown
-31.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%+0.5%+0.8%+1.4%
7D-1.0%+1.1%-2.2%-0.8%
30D-29.3%+6.3%-35.6%-28.4%
3M+5.5%+1.8%+3.7%+6.3%
6M-2.9%+1.7%-4.5%-2.1%
YTD+61.5%+6.5%+54.9%+57.5%
1Y+46.9%+9.5%+37.4%+43.0%
All+46.9%+9.8%+37.1%+43.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling